We take great care to price our medicines based on the cost to develop them, the scientific innovation they represent, and the value they deliver to patients and physicians. We are committed to helping patients get access to our innovative medicines, and have a variety of programs in place to help do this. For Sprycel, we have robust patient assistance programs in place, including:
Separate from these programs, the company also donates Sprycel to the Bristol-Myers Squibb Patient Assistance Foundation, Inc., an independent non-profit organization that helps uninsured patients get Bristol-Myers Squibb prescription medicines free of charge. To qualify, patients must meet certain eligibility criteria. For Sprycel, patients must be uninsured, reside in the US, and have a household income of less than $150,000 annually. Patients with Medicare Part D coverage may qualify for assistance if they meet the income and residency eligibility criteria and can demonstrate that they have spent 3% of their annual income out of pocket on prescription medicine. Further information is available here.
Additionally, Bristol-Myers Squibb donates to non-profit independent co-pay foundations that help underinsured cancer patients with their out-of-pocket disease related expenses that are not covered by their insurance plans, regardless of treatment selected. Medicare patients may qualify for this type of assistance, depending on the independent criteria established by these organizations.